LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Anbio Biotechnology

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERNNNN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / NNNN COVERAGE

What’s moving Anbio Biotechnology now

Current reporting with the operating signal separated from the noise.

01
TradingKey

Anbio Biotechnology (NNNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes Anbio Biotechnology’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest NNNN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-05-19 · Period 2026-05-19SEC ↗6-KOfficial SEC filingFiled 2026-04-27 · Period 2026-04-27SEC ↗F-3ASROfficial SEC filingFiled 2026-07-09SEC ↗3Official SEC filingFiled 2026-06-12 · Period 2026-03-18SEC ↗3Official SEC filingFiled 2026-06-12 · Period 2026-03-18SEC ↗20-F/AOfficial SEC filingFiled 2026-04-09 · Period 2025-12-31SEC ↗3Official SEC filingFiled 2026-04-08 · Period 2026-03-18SEC ↗3Official SEC filingFiled 2026-04-08 · Period 2026-03-18SEC ↗
EARNINGS / QUARTERLY TRACKER

Anbio Biotechnology, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.